Hyperaldosteronism Clinical Trials

6 recruiting

Hyperaldosteronism Trials at a Glance

10 actively recruiting trials for hyperaldosteronism are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Chengdu, Chicago, and Beijing. Lead sponsors running hyperaldosteronism studies include Chinese Academy of Medical Sciences, Fuwai Hospital, Duke University, and AstraZeneca.

Browse hyperaldosteronism trials by phase

Treatments under study

About Hyperaldosteronism Clinical Trials

Looking for clinical trials for Hyperaldosteronism? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperaldosteronism trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperaldosteronism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 3

A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism

Primary Hyperaldosteronism
AstraZeneca250 enrolled89 locationsNCT07007793
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Not Applicable

Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism

Idiopathic HyperaldosteronismHyperaldosteronism
Chinese Academy of Medical Sciences, Fuwai Hospital172 enrolled3 locationsNCT07328230
Recruiting
Phase 2

Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

HypercortisolismHyperaldosteronismCushing s Syndrome
National Cancer Institute (NCI)80 enrolled1 locationNCT06246357
Recruiting

CHina Adrenal Venous saMPling InvestigatiON

AdrenalectomyHyperaldosteronismAdrenal Venous Sampling
Chinese Academy of Medical Sciences, Fuwai Hospital5,000 enrolled76 locationsNCT07252284
Recruiting
Not Applicable

PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism

Primary AldosteronismSecondary HypertensionAldosterone-Producing Adenoma+2 more
Seoul National University Hospital90 enrolled2 locationsNCT07027254
Recruiting
Not Applicable

Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment

Primary Hyperaldosteronism Due to Adrenal Adenoma
Göteborg University80 enrolled3 locationsNCT05797558
Recruiting

Primary Aldosteronism in Western Norway

Hyperaldosteronism
Haukeland University Hospital300 enrolled2 locationsNCT02832388
Recruiting
Not Applicable

Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)

DiabetesInterstitial Lung DiseaseCoronary Artery Disease+10 more
Hospices Civils de Lyon339 enrolled1 locationNCT04328181
Recruiting

Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn

HypertensionEssential HypertensionAldosterone-Producing Adenoma+5 more
University Hospital Padova35 enrolled1 locationNCT06090617